The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis
Open accessAbstract
Prolactin, growth hormone and placental lactogen are members of a family of polypeptide hormones which share structural similarities and biological activities. Numerous functions have been attributed to these hormones, among which stand out their recently discovered effects on angiogenesis, the process by which new blood vessels are formed from the pre-existing microvasculature. Prolactin, growth hormone and placental lactogen, along with two non-classical members of the family, proliferin and proliferin-related protein, can act both as circulating hormones and as paracrine/autocrine factors to either stimulate or inhibit various stages of the formation and remodeling of new blood vessels, including endothelial cell proliferation, migration, protease production and apoptosis. Such opposing actions can reside in similar but independent molecules, as is the case of proliferin and proliferin-related protein, which stimulate and inhibit angiogenesis respectively. The potential to exert opposing effects on angiogenesis can also reside within the same molecule as the parent protein can promote angiogenesis (i.e. prolactin, growth hormone and placental lactogen), but after proteolytic processing the resulting peptide fragment acquires anti-angiogenic properties (i.e. 16 kDa prolactin, 16 kDa growth hormone and 16 kDa placental lactogen). The unique properties of the peptide fragments versus the full-length molecules, the regulation of the protease responsible for specific protein cleavage, the selective expression of specific receptors and their associated signal transduction pathways are issues that are being investigated to further establish the precise contribution of these hormones to angiogenesis under both physiological and pathological situations. In this review article, we summarize the known and speculative issues underlying the effects of the prolactin, growth hormone and placental lactogen family of proteins on angiogenesis, and address important remaining enigmas in this field of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Biochemical and Biophysical Research Communications
(1960) · Nature · doi:10.1038/186124d0 · Cited by 6,700
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 2×
“In this review article, we summarize the known and speculative issues underlying the effects of the prolactin, growth hormone and placental lactogen family of proteins on angiogenesis, and address important remaining enigmas in this field of research.”
BackgroundMethodInvestigative Ophthalmology and Visual Science
Frey, C. (2010) · Cited by 3,350
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457 · cited 2×
“More than 300 functions have been described for PRL, including actions on reproduction, osmoregulation, behavior, immune regulation, growth, and metabolism (Ben-Jonathan et al. 1996, Bole-Feysot et al. 1998, Freeman et al. 2000).”
BackgroundMolecular and cellular endocrinology
(1995) · Journal of Endocrinology · doi:10.1677/joe.0.147so19 · Cited by 1,991
Bole-Feysot, C., Goffin, V., Edery, M., Binart, N., & Kelly, P. A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0334 · Cited by 1,938
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
Jiménez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L., & Bouck, N. (2000) · Nature Medicine · doi:10.1038/71517 · Cited by 1,020
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004 · cited 2×
“Some of the specific regulators of angiogenesis are already undergoing phase I, II and III clinical trials (for reviews see Twardowski & Gradishar 1997, Nelson 1998, Ferrara & Alitalo 1999, Carmeliet & Jain 2000, Hagedorn & Bikfalvi 2000, Kerbel 2000, Thompson et al. 2000).”
BackgroundMethodTumor angiogenesis: past, present and the near future
Kerbel, R. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.505 · Cited by 976
Jaks and Stats in signaling by the cytokine receptor superfamily
Ihle, J. N., & Kerr, I. M. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89000-9 · Cited by 898
Ohlsson, C., Bengtsson, B.-A., Isaksson, O. G. P., Andreassen, T. T., & Slootweg, M. C. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0324 · Cited by 855
Synthesis, transport, and release of posterior pituitary hormones
Brownstein, M. J., Russell, J. T., & Gainer, H. (1980) · Science · doi:10.1126/science.6153132 · Cited by 838
Gale, N. W., & Yancopoulos, G. D. (1999) · Genes & Development · doi:10.1101/gad.13.9.1055 · Cited by 784
Holash, J., Wiegand, S. J., & Yancopoulos, G. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203035 · Cited by 744
Extrapituitary Prolactin: Distribution, Regulation, Functions, and Clinical Aspects*
BEN-JONATHAN, N., MERSHON, J. L., ALLEN, D. L., & STEINMETZ, R. W. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-639 · Cited by 734
Role of vascular endothelial growth factor in the regulation of angiogenesis
Ferrara, N. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00610.x · Cited by 731
The Prolactin/Growth Hormone Receptor Family
KELLY, P. A., DJIANE, J., POSTEL-VINAY, M.-C., & EDERY, M. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-3-235 · Cited by 727
Trends in Endocrinology and Metabolism 1998
Brines, R. (1998) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(98)00013-7 · Cited by 699
Horseman, N. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.6926 · Cited by 650
Montesano, R., Orci, L., & Vassalli, P. (1983) · The Journal of cell biology · doi:10.1083/jcb.97.5.1648 · Cited by 647
The Insulin-Like Growth Factors
Cohick, W. S., & Clemmons, D. R. (1993) · Annual Review of Physiology · doi:10.1146/annurev.ph.55.030193.001023 · Cited by 638
Endostatin Induces Endothelial Cell Apoptosis
Dhanabal, M., Ramchandran, R., Waterman, M. J. F., Lu, H., Knebelmann, B., Segal, M., & Sukhatme, V. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11721 · Cited by 584
Smith, L. E. H., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., et al. (1999) · Nature Medicine · doi:10.1038/70963 · Cited by 556
Bazan, J. F. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91528-3 · Cited by 546
Bôle‐Feysot, C. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.225 · Cited by 477
Growth Hormone Heterogeneity: Genes, Isohormones, Variants, and Binding Proteins
BAUMANN, G. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-4-424 · Cited by 443
King, G. L., Goodman, A. D., Buzney, S., Moses, A., & Kahn, C. R. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111764 · Cited by 437
Structural Variants of Prolactin: Occurrence and Physiological Significance
SINHA, Y. N. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-354 · Cited by 433
Endothelial Cell Apoptosis in Angiogenesis and Vessel Regression
Dimmeler, S., & Zeiher, A. M. (2000) · Circulation Research · doi:10.1161/01.res.87.6.434 · Cited by 425
Angiogenesis and angiogenesis inhibition: An overview
Folkman, J. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_1 · Cited by 410
The role of nitric oxide in inflammation and immunity
Clancy, R. M., Amin, A. R., & Abramson, S. B. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1141::aid-art2>3.0.co;2-s · Cited by 409
Murakami, M., Narazaki, M., Hibi, M., Yawata, H., Yasukawa, K., Hamaguchi, M., Taga, T., & Kishimoto, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11349 · Cited by 408
Basu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
Smith, L. E. H., Kopchick, J. J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R. G., & Schaeffer, J. M. (1997) · Science · doi:10.1126/science.276.5319.1706 · Cited by 393
Clinical and Experimental Pharmacology and Physiology
Fink, B. R. (1974) · Anesthesiology · doi:10.1097/00000542-197411000-00036 · Cited by 387
NICOLL, C. S., MAYER, G. L., & RUSSELL, S. M. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-2-169 · Cited by 353
Claesson-Welsh, L., Welsh, M., Ito, N., Anand-Apte, B., Soker, S., Zetter, B., O’Reilly, M., & Folkman, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5579 · Cited by 349
The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
Clapp, C., MARTIAL, J. A., Guzman, R. C., Rentier-Delure, F., & Weiner, R. I. (1993) · Endocrinology · doi:10.1210/en.133.3.1292 · Cited by 340
Self-citationThe Hemostatic System as a Regulator of Angiogenesis
Browder, T., Folkman, J., & Pirie-Shepherd, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1521 · Cited by 316
Sonntag, W. E., Lynch, C. D., Cooney, P. T., & Hutchins, P. M. (1997) · Endocrinology · doi:10.1210/endo.138.8.5330 · Cited by 307
Ausprunk, D. H., Knighton, D. R., & Folkman, J. (1974) · Developmental Biology · doi:10.1016/0012-1606(74)90004-9 · Cited by 300
The hematopoietin receptor superfamily
Cosman, D. (1993) · Cytokine · doi:10.1016/1043-4666(93)90047-9 · Cited by 295
Nicosia, R. F., Nicosia, S. V., & Smith, M. (1994) · PubMed · Cited by 293
Guo, N., Krutzsch, H. C., Inman, J. K., & Roberts, D. D. (1997) · PubMed · Cited by 293
GOFFIN, V., SHIVERICK, K. T., KELLY, P. A., & MARTIAL, J. A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-385 · Cited by 293
Insulin-like Growth Factors: Studies in Diabetics with and without Retinopathy
Merimee, T. J., Zapf, J., & Froesch, E. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309013090904 · Cited by 280
Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D’Angelo, G., Goffin, V., Weiner, R. I., & Martial, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1246 · Cited by 279
Poulsen, J. E. (1953) · Diabetes · doi:10.2337/diab.2.1.7 · Cited by 278
Grant, M., Russell, B., Fitzgerald, C., & Merimee, T. J. (1986) · Diabetes · doi:10.2337/diab.35.4.416 · Cited by 268
Yasuda, Y., Masuda, S., Chikuma, M., Inoue, K., Nagao, M., & Sasaki, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25381 · Cited by 262
Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein
Jackson, D., Volpert, O., Bouck, N., & Linzer, D. (1994) · Science · doi:10.1126/science.7527157 · Cited by 247
Franck-Lissbrant, I., Häggström, S., Damber, J.-E., & Bergh, A. (1998) · Endocrinology · doi:10.1210/endo.139.2.5683 · Cited by 236
Growth hormone: roles in female reproduction
Hull, K., & Harvey, S. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1680001 · Cited by 234
Multiple forms of angiostatin induce apoptosis in endothelial cells.
Lucas, R., Holmgren, L., Garcia, I., Jiménez, B., Mandriota, S. J., Borlat, F., Sim, B. K. L., Wu, Z., Grau, G. E., Shing, Y., et al. (1998) · PubMed · doi:10.1182/blood.v92.12.4730 · Cited by 227
D'Angelo, G., Struman, I., Martial, J., & Weiner, R. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6374 · Cited by 227
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
Eklund, L., Piuhola, J., Komulainen, J., Sormunen, R., Ongvarrasopone, C., Fässler, R., Muona, A., Ilves, M., Ruskoaho, H., Takala, T. E. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1194 · Cited by 226
Meyer-Schwickerath, R., Pfeiffer, A., Blum, W. F., Freyberger, H., Klein, M., Lösche, C., Röllmann, R., & Schatz, H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116877 · Cited by 224
Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors.
Lee, S. J., & Nathans, D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69101-x · Cited by 221
Human Growth Hormone: A Complex of Proteins
Lewis, U. J., Singh, R. N. P., Tutwiler, G. F., Sigel, M. B., VanderLaan, E. F., & VanderLaan, W. P. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-571136-4.50019-x · Cited by 218
Insulin-like growth factor I and its binding proteins in the cardiovascular system
DELAFONTAINE, P. (1995) · Cardiovascular Research · doi:10.1016/0008-6363(95)00163-8 · Cited by 216
FERRARA, N., CLAPP, C., & WEINER, R. (1991) · Endocrinology · doi:10.1210/endo-129-2-896 · Cited by 212
Self-citationAngiogenesis: Models and Modulators
Cockerill, G. W., Gamble, J. R., & Vadas, M. A. (1995) · International Review of Cytology · doi:10.1016/s0074-7696(08)62106-3 · Cited by 195
LOBIE, P. E., BREIPOHL, W., GARCÍA ARAGÓN, J., & WATESR, M. J. (1990) · Endocrinology · doi:10.1210/endo-126-4-2214 · Cited by 195
Grant, M. B., Mames, R. N., Fitzgerald, C., Ellis, E. A., Aboufriekha, M., & Guy, J. (1993) · Diabetologia · doi:10.1007/bf00400229 · Cited by 191
Kim, K., Bae, S. K., Lee, O., Bae, M.-H., Lee, M. J., & Park, B. C. (1998) · PubMed · Cited by 190
Bacharach, E., Itin, A., & Keshet, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10686 · Cited by 182
Diabetic Retinopathy: A Synthesis of Perspectives
Epstein, F. H., & Merimee, T. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221406 · Cited by 181
Molecular Actions of Prolactin in the Immune System
Yu-Lee, L.-Y. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-215-44111 · Cited by 171
Linzer, D. I., & Nathans, D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4255 · Cited by 169
Clapp, C., & Weiner, R. I. (1992) · Endocrinology · doi:10.1210/endo.130.3.1311239 · Cited by 167
Self-citationLactogenic and Growth Hormone-Like Activities in Pregnancy Determined by Radioreceptor Assays
Kelly, P. A., Tsushima, T., & Shiu, R. P. C. (1976) · Endocrinology · doi:10.1210/endo-99-3-765 · Cited by 156
Identification of proliferin mRNA and protein in mouse placenta.
Linzer, D. I. H., Lee, S. J., Ogren, L., Talamantes, F. J., & Nathans, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4356 · Cited by 151
Nakao‐Hayashi, J., Ito, H., Kanayasu, T., Morita, I., & Murota, S. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90273-j · Cited by 150
A Follow-up Study of Vascular Disease in Growth-Hormone-Deficient Dwarfs with Diabetes
Merimee, T. J. (1978) · New England Journal of Medicine · doi:10.1056/nejm197806012982202 · Cited by 148
Trophoblastic Giant Cells of the Mouse Placenta as the Site of Proliferin Synthesis*
Lee, S. M., Talamantes, F. J., WILDER, E., Linzer, D. I. H., & Nathans, D. (1988) · Endocrinology · doi:10.1210/endo-122-5-1761 · Cited by 143
The Uteroplacental Prolactin Family and Pregnancy1
Soares, M. J., Müller, H., Orwig, K. E., Peters, T. J., & Dai, G. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.2.273 · Cited by 138
Mittra, I. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(80)80101-x · Cited by 134
Carney, E. W., Prideaux, V. R., Lye, S. J., & Rossant, J. (1993) · Molecular Reproduction and Development · doi:10.1002/mrd.1080340403 · Cited by 124
Angiogenesis in Ischemic Disease
Risau, W., & Marti, H. H. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615552 · Cited by 122
A new member of the prolactin‐growth hormone gene family expressed in mouse placenta.
Linzer, D. I. H., & Nathans, D. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03796.x · Cited by 122
Goffin, V., Kinet, S., Ferrag, F., Binart, N., MARTIAL, J. A., & Kelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16573 · Cited by 122
Volpert, O. V., Jackson, D., Bouck, N., & Linzer, D. I. H. (1996) · Endocrinology · doi:10.1210/endo.137.9.8756559 · Cited by 121
INSULIN-LIKE GROWTH FACTOR-I MODULATES ENDOTHELIAL CELL CHEMOTAXIS
Grant, M. B., Jerdan, J. A., & Merimee, T. J. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-2-370 · Cited by 121
Insulin, insulin-like growth factors, and vascular endothelium
Bar, R. S., Boes, M. A., Dake, B. L., Booth, B. A., Henley, S. A., & Sandra, A. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90398-1 · Cited by 120
The Placenta and the Prolactin Family of Hormones: Regulation of the Physiology of Pregnancy
Linzer, D. I. H., & Fisher, S. J. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0286 · Cited by 119
Interleukin-15 Promotes Angiogenesisin Vivo
Angiolillo, A. L., Kanegane, H., Sgadari, C., Reaman, G. H., & Tosato, G. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6435 · Cited by 118
Target molecules for anti-angiogenic therapy: from basic research to clinical trials
Hagedorn, M., & Bikfalvi, A. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00056-1 · Cited by 116
Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
OʼReilly, M. (1997) · PubMed · Cited by 115
Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
Albini, A., Florio, T., Giunciuglio, D., Masiello, L., Carlone, S., Corsaro, A., Thellung, S., Cai, T., Noonan, D. M., & Schettini, G. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.6.647 · Cited by 115
Clapp, C., Torner, L., Gutiérrez‐Ospina, G., Alcántara, E., López-Gómez, F. J., Nagano, M. C., Kelly, P. A., Mejía, S., Morales, M. A., & de la Escalera, G. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10384 · Cited by 108
Self-citationFactors Promoting Tumor Angiogenesis: Special Article
Beckner, M. E. (1999) · Cancer Investigation · doi:10.3109/07357909909032845 · Cited by 100
Angiogenesis and ophthalmic disease
Adamis, A. P., Aiello, L. P., & D’Amato, R. A. (1999) · Angiogenesis · doi:10.1023/a:1009071601454 · Cited by 100
Lee, O.-H., Bae, S. K., Bae, M., Lee, Y. M., Moon, E., J, H., Kwon, Y., & Kim, K. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0931 · Cited by 99
D’Angelo, G., Martini, J., Iiri, T., Fantl, W. J., MARTIAL, J. A., & Weiner, R. I. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.5.0280 · Cited by 97
Lowman, H. B., Cunningham, B., & Wells, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99116-7 · Cited by 96
Wang, F., Samudio, I. J., & Safe, S. H. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00379-8 · Cited by 91
Dueñas, Z., Torner, L., Corbacho, A., Ochoa, A., Gutiérrez‐Ospina, G., López-Barrera, F., Barrios, F. A., Berger, P., de la Escalera, G. M., & Clapp, C. (1999) · PubMed · Cited by 88
Self-citationClapp, C. (1987) · Endocrinology · doi:10.1210/endo-121-6-2055 · Cited by 85
Self-citationChiang, C., & Nilsen‐Hamilton, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67407-1 · Cited by 84
Growth hormone: A paracrine growth factor?
Harvey, S., & Hull, K. (1997) · Endocrine · doi:10.1007/bf02801319 · Cited by 84
Inhibitors of Angiogenesis Enter Phase III Testing
Nelson, N. J. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.13.960a · Cited by 80
Toft, D. J., Rosenberg, S. B., Bergers, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231364798 · Cited by 80
The proline-rich motif (PRM): a novel feature of the cytokine/hematopoietin receptor superfamily.
O’Neal, K. D., & Yu‐Lee, L. (1993) · PubMed · Cited by 80
Grant, M. B., & Guay, C. (1991) · PubMed · Cited by 79
Lee, H., Struman, I., Clapp, C., MARTIAL, J. A., & Weiner, R. I. (1998) · Endocrinology · doi:10.1210/endo.139.9.6194 · Cited by 79
Self-citationInsulin-like growth factor I gene expression in vascular cells.
Delafontaine, P., Bernstein, K. E., & Alexander, R. W. (1991) · Hypertension · doi:10.1161/01.hyp.17.5.693 · Cited by 77
Groskopf, J. C., Syu, L.-J., Saltiel, A. R., & Linzer, D. I. H. (1997) · Endocrinology · doi:10.1210/endo.138.7.5276 · Cited by 77
Reduced Retinal Vascularization in Children with Growth Hormone Deficiency
Hellström, A., Svensson, E., Carlsson, B., Niklasson, A., & Albertsson-Wikland, K. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5484 · Cited by 77
Kern, P. A., SVOBODA, M. E., Eckel, R. H., & Wyk, J. J. V. (1989) · Diabetes · doi:10.2337/diab.38.6.710 · Cited by 75
Clapp, C., López-Gómez, F. J., Nava, G., Corbacho, A., Torner, L., Macotela, Y., Dueñas, Z., Ochoa‐Zarzosa, A., Noris, G., Acosta, E., et al. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1580137 · Cited by 73
Self-citationMechanisms of retinal angiogenesis
Stone, J., & Maslim, J. (1997) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(96)00019-5 · Cited by 70
Use of a model to understand prolactin and growth hormone specificities
Goffin, V., MARTIAL, J. A., & Summers, N. L. (1995) · Protein Engineering Design and Selection · doi:10.1093/protein/8.12.1215 · Cited by 69
Rymaszewski, Z., Cohen, R. M., & Chomczyński, P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.617 · Cited by 69
Sharara, F. I., & Nieman, L. K. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.7519196 · Cited by 67
Cleaved Prolactin: Evidence for Its Occurrence in Human Pituitary Gland and Plasma*
Sinha, Y. N., Gilligan, T., LEE, D. W., Hollingsworth, D. R., & Markoff, E. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-2-239 · Cited by 66
Waters, M. J., Shang, C. A., Behncken, S. N., Tam, S. P., Li, H., Shen, B., & Lobie, P. E. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03129.x · Cited by 65
Franck-Lissbrant, I. (1998) · Endocrinology · doi:10.1210/en.139.2.451 · Cited by 63
Clinical trials of antiangiogenic agents
Twardowski, P. W., & Gradishar, W. J. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199711000-00015 · Cited by 62
Bentzien, F., Struman, I., Martini, J.-F., MARTIAL, J. A., & Weiner, R. I. (2001) · PubMed · Cited by 55
Proteolytic Cleavage Confers Nitric Oxide Synthase Inducing Activity upon Prolactin
Corbacho, A. M., Nava, G., Eiserich, J. P., Noris, G., Macotela, Y., Struman, I., de la Escalera, G. M., Freeman, B. Α., & Clapp, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13183 · Cited by 54
Self-citationGould, J. C., Arámburo, C., Capdevielle, M. C., & Scanes, C. G. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00491-a · Cited by 53
Endogenous Angiogenesis Inhibitors: Angiostatin, Endostatin, and Other Proteolytic Fragments
Cao, Y. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-72149-6_8 · Cited by 52
Growth Factors and Diabetic Complications
Flyvbjerg, A. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01413.x · Cited by 52
Biological effects of growth hormone and its antagonist
Okada, S., & Kopchick, J. J. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)01933-5 · Cited by 51
Human umbilical vein endothelial cells express multiple prolactin isoforms
Corbacho, A., Macotela, Y., Nava, G., et al. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660053 · Cited by 51
Self-citationDiabetes mellitus and sexual ateliotic dwarfism: a comparative study
Merimee, T. J., Fineberg, S. E., McKusick, V. A., & Hall, J. G. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106325 · Cited by 50
Torner, L., Mejía, S., López-Gómez, F. J., Quintanar, A., de la Escalera, G. M., & Clapp, C. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588295 · Cited by 49
Self-citationSinha, Y. N., & Gilligan, T. (1984) · Endocrinology · doi:10.1210/endo-114-6-2046 · Cited by 49
Expression of prolactin gene and secretion of prolactin by rat retinal capillary endothelial cells.
Ochoa, A., de Oca, P. M., Rivera, J. C., Dueñas, Z., Nava, G., de la Escalera, G. M., & Clapp, C. (2001) · PubMed · Cited by 46
Self-citationRetinal Changes Mimicking Diabetic Retinopathy in Two Nondiabetic, Growth Hormone-Treated Patients1
Koller, E. A., Green, L., Gertner, J. M., Bost, M., & Malozowski, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4953 · Cited by 46
Metabolic control and serum hormone levels in relation to retinopathy in diabetic pregnancy
LARINKARI, J., Laatikainen, L., Ranta, T., M�r�nen, P., Pesonen, K., & Laatikainen, T. K. (1982) · Diabetologia · doi:10.1007/bf00253576 · Cited by 44
Torner, L., Nava, G., Dueñas, Z., Corbacho, A., Mejía, S., López, F. J. G., Cajero, M., de la Escalera, G. M., & Clapp, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610423 · Cited by 44
Self-citationA two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathy
Hyer, S. L., Sharp, P. S., Brooks, R. A., Burrin, J. M., & KOHNER, E. M. (1989) · Metabolism · doi:10.1016/0026-0495(89)90222-9 · Cited by 43
Involvement of nitric oxide in the inhibition of angiogenesis by interleukin‐2
Sakkoula, E., Pipili‐Synetos, E., & Maragoudakis, M. E. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701436 · Cited by 43
Mejía, S., Morales, M. A., Zetina, M. E., de la Escalera, G. M., & Clapp, C. (2008) · Neuroendocrinology · doi:10.1159/000127233 · Cited by 42
Self-citationMerkle, C. J., Schuler, L. A., Schaeffer, R. C., Gribbon, J. M., & Montgomery, D. W. (2000) · Endocrine · doi:10.1385/endo:13:1:37 · Cited by 40
2 Endothelial cell proteases: Physiological role and regulation
Ménashi, S., Lu, H., Soria, C., & Legrand, Y. (1993) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80188-x · Cited by 39
Role of Dopamine in Malignant Tumor Growth
Basu, S., & Dasgupta, P. (2000) · Endocrine · doi:10.1385/endo:12:3:237 · Cited by 39
Angiostatin: An endogenous inhibitor of angiogenesis and of tumor growth
OʼReilly, M. (1997) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9006-9_11 · Cited by 39
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
Eklund, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031444798 · Cited by 38
Mrp3, a Mitogen-Regulated Protein/Proliferin Gene Expressed in Wound Healing and in Hair Follicles
Fassett, J. T., & Nilsen‐Hamilton, M. (2001) · Endocrinology · doi:10.1210/endo.142.5.8132 · Cited by 37
Hyperprolactinaemia in male diabetics
Mooradian, A. D., Morley, J. E., Billington, C. J., Slag, M. F., Elson, M. K., & Shafer, R. B. (1985) · Postgraduate Medical Journal · doi:10.1136/pgmj.61.711.11 · Cited by 36
Prolactin and prolactin-like polypeptides in rheumatoid arthritis
Neidhart, M., Gay, R. E., & Gay, S. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80091-2 · Cited by 35
Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis
Ferrara, N. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-453-5_8 · Cited by 32
Pietras, R. J., & Szego, C. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222313 · Cited by 32
Pituitary ablation for diabetic retinopathy. I. Results of hypophysectomy. (A ten-year evaluation)
Ray, B. S. (1968) · JAMA · doi:10.1001/jama.203.2.79 · Cited by 32
Inhibition of Tumor Growth by the Antiangiogenic Placental Hormone, Proliferin-Related Protein
Bengtson, N. W., & Linzer, D. I. H. (2000) · Molecular Endocrinology · doi:10.1210/me.14.12.1934 · Cited by 29
Identification of Three Prolactin-Related Hormones as Markers of Invasive Trophoblasts in the Rat1
Toft, D. J., & Linzer, D. I. H. (2000) · Biology of Reproduction · doi:10.1095/biolreprod63.2.519 · Cited by 25
Retinal Changes Mimicking Diabetic Retinopathy in Two Nondiabetic, Growth Hormone-Treated Patients
Koller, E. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2380 · Cited by 22
Rat prolactin synthesis by lactating mammary epithelial cells
Lkhider, M., Delpal, S., Provost, F. L., & Ollivier‐Bousquet, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01450-0 · Cited by 20
Prolactins: Novel Regulators of Angiogenesis
Clapp, C., & de la Escalera, G. M. (1997) · Physiology · doi:10.1152/physiologyonline.1997.12.5.231 · Cited by 20
Self-citationGrowth Hormone Replacement Therapy Is Not Associated with Retinal Changes
Blank, D., Riedl, M., Reitner, A., Schnack, C., Schernthaner, G., Clodi, M., Frisch, H., & Luger, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.634 · Cited by 17
Hansen, R., Koller, E. A., & Malozowski, S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6686-1 · Cited by 15
Proteolytic Modification of Prolactin by the Female Rat Brain
DeVito, W. J., Avakian, C., & Stone, S. (2008) · Neuroendocrinology · doi:10.1159/000126279 · Cited by 11
Comment on Growth Hormone Therapy and Retinal Changes Mimicking Diabetic Retinopathy
Radetti, G., Gentili, L., & Lepidi, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6415-1 · Cited by 10
On the Possible Role of Endothelial Cell Heterogeneity in Angiogenesis
Lelkes, P. I., Manolopoulos, V. G., Silverman, M. D., Zhang, S., Karmiol, S., & Unsworth, B. R. (1996) · Springer eBooks · doi:10.1007/978-1-4613-0389-3_1 · Cited by 10
Growth Hormone and Endothelial Function during Exercise in Diabetics with and without Retinopathy
Sundkvist, G., Almér, L., Lilja, B., & Pandolfi, M. (1984) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1984.tb04969.x · Cited by 9
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Cited by
Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
Gellersen, B., & Brosens, J. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1045 · Cited by 1,139
Growth and function of the normal human placenta
Gude, N. M., Roberts, C. T., Kalionis, B., & King, R. G. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.038 · Cited by 1,029
A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy
Hilfiker-Kleiner, D., Kaminski, K., Podewski, E., Bonda, T., Schaefer, A., Sliwa, K., Forster, O., Quint, A., Landmesser, U., Doerries, C., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.036 · Cited by 906
The Molecular Control of Corpus Luteum Formation, Function, and Regression
Stocco, C., Telleria, C., & Gibori, G. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0022 · Cited by 731
Endogenous Inhibitors of Angiogenesis
Nyberg, P., Xie, L., & Kalluri, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2427 · Cited by 553
Metadata
- Authors
- Corbacho, A., Martinez De La Escalera, G., & Clapp, C.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2002-05-01
- Volume
- 173
- Issue
- 2
- Pages
- 219-238
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2153104756
- Cited by
- 256
- References
- 164
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.